In this study, we showed that exogenous NPRL2 expression in NPRL2-negative tumor cells activated the DNA damage pathway, as evidenced by activation of ATM and NBS1 and increased γ-H2AX expression in lung cancer cells after NPRL2 treatment. This evidence concerns the gene ATM and neoplasm.